Arkolith/Insider Trading/CMPI/Form 4

venBio Global Strategic Fund II L.P.

10% OwnerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed Apr 29, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2022Sell(S)69K$10.38$719K2.8M
Apr 28, 2022Sell(S)73K$10.38$762K2.9M
Apr 27, 2022Sell(S)47K$10.38$492K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-009203) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML